LIFE. OPTIMIZED.

Vytalyx is a blockchain-based health platform that uses the power of Augmented Intelligence (AI), Machine Learning (ML), Big Data Analytics and unprecedented amounts of data to personalize your health.

ADVANCING HEALTH THROUGH COGNITIVE TECHNOLOGIES

Imagine a world . . .

TOKENIZING THE PERSONALIZATION OF YOUR HEALTH

Imagine a world . . .

IMAGINE A WORLD. . .

Where AI and blockchain converge to create a singular source for the optimization of your health. Where you can track your health and predict, in real-time, what your next action should be. Where we arm health professionals with massive amounts of data to drive the best possible outcomes for you. Where an unparalleled array of information is processed to create products and services personalized to you. Where we tokenize the personalization of your health. Where you own your data and control your health. This is where your life is personalized, optimized and tokenized. This is the future. This is Vytalyx.

WHAT WE DO

We use AI, machine learning, big data analytics and unprecedented amounts of data to provide personalized compounded drug and dietary supplement formulations, personalized clinical decision support (CDS), patient decision support (PDS) and evidence-based medicine (EBM) tools as well as personalized nutrition and fitness programs – all through decentralization, cryptography and utilization of blockchain. In today’s world, we believe that patients are seeking care from a fragmented system in which numerous health professionals are making clinical decisions with limited data sets, rather than making more accurate clinical decisions using technologies that can analyze all available information.  More importantly, the personal health information (PHI) created by these providers is not owned or controlled by the patient nor is it standardized, portable or interoperable amongst providers, thereby making access to patient records a cumbersome and inefficient process.  We solve these problems.  Vytalyx leverages data to improve health outcomes, empowers you with data ownership and puts you in control of your own health.

PERSONALIZED & TOKENIZED HEALTH

AI Outputs

RX | DIETARY SUPPLEMENTS

CLINICAL DECISION SUPPORT (CDS) | PATIENT DECISION SUPPORT (PDS) | EVIDENCE-BASED MEDICINE (EBM)

NUTRITION | FITNESS

PROBLEMS WE SOLVE

  • “Healthcare is fragmented, heavily standardized and lacks a centralized, integrated and comprehensive solution.”
  • “Consumers are concerned with data privacy and do not control or own their personal health information.”
  • “The human body is extremely complex and requires advanced technology to solve these complexities.”
  • “Health professionals do not have the computational power to process millions of data points.”
  • “Electronic health records lack sufficient amounts of wellness, nutrition and fitness data.”
  • “Healthcare is increasingly becoming a software and data management problem.”
  • “Standardization is being used for treatment rather than personalization.”

OUR TARGET MARKET

PATIENTS | CONSUMERS | CORPORATES

DOCTORS | HOSPITALS | HEALTHCARE FACILITIES

DATA BUYERS | EMR FIRMS | MEDICAL RESEARCH FIRMS

DIETITIANS | NUTRITIONISTS | TRAINERS | GYMS

PATIENT EXPERIENCE

  • PROVIDE MEDICAL HISTORY

    Complete questionnaire either online or mobile app. Questionnaire will contain detailed questions regarding your health, nutrition and exercise history and will provide access to your medical history for integration into our AI.

  • GET TESTED

    Test biochemical, genomic, microbiome, protein and/or telomere data for integration into our AI. Most tests may be conducted by visiting our lab partner, who has over 2000 testing centers in the US, while other tests may be tested via home testing kit.

  • GET ANALYZED

    Your health professional will review questionnaire, medical history and test results, determine the proper treatment protocol using our CDS/EBM modules, and will provide you a report indicating the personalized RX, supplement, nutrition or exercise program.

  • ORDER RX & SUPPLEMENTS

    Based on the treatment protocol prescribed by your health professional, order the recommended medications and dietary supplements. All orders for medications will require a written prescription from your licensed medical practitioner.

  • MONITOR ACTIVITY

    Follow/track the recommended treatment protocol prescribed by your health professional, including periodic biomarker and other testing, as well as monitoring your day-to-day activity using a number of real-time devices that connect to our AI.

WHY ARE WE DIFFERENT?

The efficacy of a particular treatment or protocol can be directly correlated to the amount of data analyzed and how any such findings may be shared amongst health professionals.  The Vytalyx AI plans to integrate and analyze more data from more sources and more subject matter experts (SMEs) than any other health solution on the market, thereby improving lives and creating a universal health record on the Vytalyx Blockchain that is mutually beneficial for patients and caregivers.

 

The optimization of one’s health lacks comprehensiveness and involves numerous, concatenated and disconnected steps – separate visits to one’s doctor, laboratory, pharmacy, nutritionist, personal trainer and supplement store. Often, opinions from different health professionals lead to separate or conflicting conclusions.  As a result, health professionals may be analyzing only a fraction of the data needed in order to fully determine the all-round condition of an individual and create a product or service that is truly personalized. What about the sea of other data? What about the inputs from multiple SMEs in each practice area? What about inputs from clinical and non-clinical research reports? What about electronic medical records for the population and underlying patient? What about our proprietary algorithms that tie everything together? We believe that most of the competition pales compared to the amount of data being integrated into the Vytalyx AI. Add the capability to create compounded drug and dietary supplement formulations on a personalized basis using the Vytalyx AI and the decentralization, cryptography and utilization of the Vytalyx Blockchain – the differentiator chasm may widen and become a paradigm shift.

 

The Vytalyx AI intends to integrate intimate knowledge from multiple SMEs in each identified practice area of medicine and uses augmented intelligence (AI), machine learning (ML) and big data analytics to determine the relationships between these SMEs against large data sets, such as EMR data (which contains anonymous patient vitals, treatment protocols, measurable outcomes and numerous use cases), genomic and biomarker data (blood, microbiome, protein, telomere), real-time data, clinical and non-clinical research reports, nutrition and fitness data as well as a plethora of drug, compounding, food, allergen and exercise information. We don’t want people to be just better informed, we want people to be fully informed with all available data to drive the best possible outcomes.

ADVANCING THE STANDARD OF CARE

The human body is extremely complex and may require advanced technologies to solve these complexities. We intend to use augmented intelligence (AI), machine learning (ML) and big data analytics to process and analyze millions of data points – a computation that no health professional could likely ever process without the use of technology. By using personalization, rather than standardization, health professionals may use our proprietary AI, the Vytalyx AI, to treat a wider range of individual responses along the intersection of the bell curves of multiple therapeutic regimens. Medical practitioners, hospitals and healthcare facilities may use the Vytalyx AI to personalize compounded Rx and dietary supplements, to potentially improve patient well-being and to potentially diagnose, treat, prevent and cure certain diseases using our clinical decision support (CDS) and evidence-based medicine (EBM) modules. Dietitians, nutritionists, personal trainers and other health professionals may use the Vytalyx AI to personalized dietary supplements and to potentially help their customers reach their health, nutrition and fitness goals or needs. Individuals may use the Vytalyx AI to optimize their health and our blockchain, the Vytalyx Blockchain, to potentially make their personal health information (PHI) more standardized, portable and interoperable between the patient and various health professionals.

** Any use of the Vytalyx AI for performance, dietary, nutrition, exercise and physical fitness purposes is not intended to diagnose, treat, cure or prevent any disease. Only medical practitioners may use the Vytalyx AI to diagnose, treat, cure or prevent any disease.

Vytalyx AI
Empowering People

EMPOWERING PEOPLE WITH DATA OWNERSHIP

Patients may not own their health records. Electronic health records (EHR) generally belong to the practitioner who created the patient’s record and the facility in which the record was created. Only the information gathered within the original medical record may be owned by the patient, as a copy and not in electronic form.  The Vytalyx AI intends to collect personal health information (PHI), both clinical and non-clinical, to potentially enable data owners and buyers to share and acquire PHI, respectively, through decentralization, cryptography and utilization of blockchain. Our tokenized ecosystem and permissioned blockchain, the Vytalyx Blockchain, will have the potential to provide higher security, increased privacy and more efficient sharing of PHI – all in a HIPAA compliant manner. By distributing and sharing one’s PHI on the Vytalyx Blockchain, data owners may eliminate various intermediaries in the EHR acquisition market, thereby potentially empowering consumers with the benefits of peer-to-peer distribution of PHI through the Vytalyx Blockchain.

LEVERAGING DATA TO IMPROVE OUTCOMES

Without analyzing all available data and information, how can you make the most informed decision? This ideology is at the center of human decision making and is the main principium of the Vytalyx AI. No matter what the decision tree is, at Vytalyx, we understand that applying augmented intelligence (AI), machine learning (ML) and big data analytics to large data sets and natural language processing (NLP) to research may be the key to solving various clinical and non-clinical associations, conditions, outcomes, effects and risks.  The purpose of Vytalyx AI is to provide health professionals with more information, data and analytics to improve patient outcomes.

Leveraging Data

HARNESSING THE POWER OF PERSONALIZATION

Using the Vytalyx AI, we intend to create personalized compounded pharmaceutical and personalized dietary supplement formulations to optimize your health.

** We intend to partner with an existing or build our own FDA registered 503B Outsourcing Facility.

OUR AI

Unlike artificial intelligence, which may involve little to no human-machine intercommunication, augmented intelligence is information technology that may be codified to mimic human cognitive functions and may supplement and support human cognition, thinking and analysis, but leaves the human at the center of human-machine interaction. The Vytalyx AI intends to integrate an unprecedented amount of data, all of which may be of paramount importance in creating personalized products and services. In order to create a personalized health solution that is effective, we believe all facets of one’s health must considered by analyzing, assessing, interpreting and predicting various clinical and non-clinical associations, conditions, outcomes, effects and risks that are specific to you. Once the Vytalyx AI determines and predicts your unique characteristics, it may provide a personalized solution for you. We intend to create products and services that are tailor-made and are supported by vast amounts of data. We plan to develop a tokenized ecosystem and permissioned blockchain, the Vytalyx Blockchain, to potentially securely access, share and distribute personal health information (PHI) data and cryptoeconomics to tokenize the personalization of your health.

Augmented Intelligence

AUGMENTED INTELLIGENCE

Machine Learning

MACHINE LEARNING

Big Data Analytics

BIG DATA ANALYTICS

Blockchain

BLOCKCHAIN

AI INPUTS

The Vytalyx AI

AI STATS

0
EST NUMBER OF DATA INPUTS
0
EST NUMBER OF INDIVIDUAL RECORDS
0
EST NUMBER OF DATA SOURCES
0
EST NUMBER OF MARKERS ANALYZED
  • Vytalyx has crafted an unprecedented strategy for capturing vast amounts of information from existing and new sources in the medical and non-medical fields and processing all inputs using advanced technologies to create highly integrated and personalized products and services that optimize one’s health under standards heretofore never adhered to.

  • With our proprietary AI, medical practitioners will have the power of numerous specialty doctors at their disposal to better treat their patients and they will be able to prescribe drugs tailored to their patients instead of following the path of standardization.

  • A game changer. Vytalyx will disrupt numerous industries in one fell swoop.  It's companies like Vytalyx that will lead the world towards greater innovation.

OUR BLOCKCHAIN

As a result of the large amounts of data collected by the Vytalyx AI, our tokenized ecosystem and permissioned blockchain, the Vytalyx Blockchain, seeks to transform the way the healthcare industry currently uses, stores, manages and distributes personal health information (PHI). The Vytalyx Blockchain plans to create a Universal Health Record (UHR), that contains clinical and non-clinical PHI, to potentially increase the portability and interoperability of PHI amongst health professionals as well as to potentially improve health outcomes – all with end-to-end encryption while adhering to regulatory guidelines and compliance requirements, including but not limited to, the Health Insurance Portability and Accountability Act of 1996 (HIPAA) and General Data Protection Regulation (GDPR). The Vytalyx Blockchain will consist of an application level token, the VYT Token, that is compliant with applicable securities laws. We intend to build our permissioned blockchain on Hyperledger Sawtooth Burrow with Proof of Elapsed Time (PoET) as our consensus algorithm. We also plan to implement a Microsoft Coco framework within an Intel Secure Guard Extensions (SGX) environment to potentially create a trusted execution environment (TEE) to share, access and distribute PHI generated by the Vytalyx AI.

Decentralized Health Records

Decentralized & Immutable Health Records

Portable Health Records

Portable & Interoperable Health Records

Health Record Ownership

Health Record Ownership & Control

Blockchain Tokenization

Tokenized Data Ownership

Peer-to-Peer

Peer-to-Peer Sale of Health Records

Blockchain Data

Secure & Encrypted Health Records

Blockchain Security

HIPAA & HITECH Compliant

Decentralized Big Data

Decentralized Big Data

FUTURE BLOCKCHAIN STRATEGIES*

Decentralized AI

Decentralized AI

AI Smart Contract

AI Trained DApps

IoT

IoT Integration

On-Chain Big Data

Big Data On-Chain

AI On-Chain

AI On-Chain

Supplychain

Supply Chain Provenance

* We plan to integrate upon advancement of current blockchain technology or future development phases.

TOKENIZING THE PERSONALIZATION OF YOUR HEALTH

Through the security and immutability of our tokenized ecosystem and permissioned blockchain, the Vytalyx Blockchain, as users of the Vytalyx Blockchain accumulate more personal health information (PHI) data through the Vytalyx AI, either through the addition of medical history, biochemical, genomic, microbiome, protein and telomere test data, wearable data, user data and outcome data (clinical and non-clinical), users may be able to sell their PHI to data buyers. As more data is collected by the user and added to his or her PHI profile, the higher the potential value of his or her data to prospective data buyers in the Vytalyx Blockchain.

DEVELOPMENT PHASES

  • Phase 1 - AI

    Development of the Vytalyx AI for use in personalizing Rx formulations, dietary supplements formulations and clinical decision support (CDS) modules for 2-4 different practice areas of medicine as well as personalized nutrition plans and fitness programs. Minimum Viable Product (MVP).

  • Phase 2 - Blockchain

    Development of the Vytalyx Blockchain, for the purposes of using, accessing, sharing and distributing clinical and non-clinical personal health information (PHI) generated or maintained by the Vytalyx AI as well as increasing PHI portability amongst PHI owners, data sellers and health professionals.

  • Phase 3 - AI

    Additional development of the Vytalyx AI for use in personalizing additional Rx formulations and additional clinical decision support (CDS) modules for 6-10 additional practice areas of medicine. Transition certain personalized CDS modules into personalized evidence-based medicine (EBM) modules.

  • Phase 4 - AI

    Additional development of the Vytalyx AI for use in analyzing, diagnosing, preventing and treating 5-10 specific disease states. Continue transition of prior clinical decision support (CDS) modules into evidence-based medicine (EBM) modules and further expansion of personalized Rx formulations.

  • Phase 5 - Blockchain

    Additional development of the Vytalyx Blockchain and integration of various superior third-generation blockchains, DAG protocols or hard fork to another blockchain from Ethereum to the Vytalyx Blockchain to increase scalability and enable more PHI data "on-chain" with smart contracts.

ROADMAP

March 1, 2017

Development of proprietary DNA Algorithms for over 200+ genomic markers

May 18, 2017

Vytalyx Inc was incorporated in Delaware

September 15, 2017

Initial design & equipment selection for 503B pharmaceutical compounding and dietary supplement facility

December 7, 2017

Commenced Convertible Debt Seed Funding

January 18, 2018

Secured LOI for commercial leasehold space

January 19, 2018

Phase 1 – Development of our database and the Vytalyx AI for use in personalizing Rx formulations, dietary supplements formulations and clinical decision support (CDS) modules for 2-4 different practice areas of medicine as well as personalized nutrition plans and fitness programs

May 14, 2018

Commenced Series A Preferred Stock Round

May 15, 2018

Phase 2 – Development and integration of our tokenized ecosystem and permissioned, the Vytalyx Blockchain, for the purposes of using, accessing, sharing and distributing clinical and non-clinical personal health information (PHI) generated or maintained by our AI as well as increasing PHI portability amongst PHI owners, data sellers and health professionals

June 1, 2018

Vytalyx Token Sale Begins

August 1, 2018

AI Prototype & Minimum Viable Product (MVP) delivered

August 15, 2018

Phase 3 – Additional development of the Vytalyx AI for use in personalizing additional Rx formulations and additional clinical decision support (CDS) modules for 6-10 additional practice areas of medicine. Transition certain personalized CDS modules into personalized evidence-based medicine (EBM) modules

September 30, 2018

Token Sale Ends

January 1, 2019

User-ready AI interface for the purposes of personalizing drug and dietary supplement formulations, personalized CDS in 2-4 practice areas of medicine as well as personalized nutrition and fitness programs

September 15, 2019

Completion of Phase 1 thru 3 of the Vytalyx AI development

September 15, 2019

Phase 4 – Additional development of the Vytalyx AI for use in analyzing, diagnosing, preventing and treating 5-10 specific disease states. Continue transition of prior clinical decision support (CDS) modules into evidence-based medicine (EBM) modules and further expansion of personalized Rx formulations

September 15, 2019

Phase 5 – Additional development of the Vytalyx Blockchain, and integration of various superior third-generation blockchains, DAG protocols or hard fork to another blockchain from Ethereum to the Vytalyx Blockchain to increase scalability and enable more PHI data “on-chain” with smart contracts

January 1, 2020

Completion of Phase 5 of the Vytalyx Blockchain development

September 15, 2020

Completion of Phase 4 of the Vytalyx AI development

TOKEN OFFERING

At Vytalyx, innovation is at the forefront of everything that we do and we believe that regulatory compliance is paramount to the continuity of our vision as well as to investor safety and overall market integrity.  We plan to conduct our token offering pursuant to Regulation D 506(c) to U.S. “accredited investors” and Regulation S to non-U.S. investors.  

Vytalyx Inc is a registered MSB with FinCEN (No. 3100025804777). For registration status, click here.

TOKEN INFORMATION

We intend to conduct a private pre-sale that consists of a series of token offerings. If we reach the total target raise, we believe that the funds raised  will finance the operations of Vytalyx for approximately one to two years. We intend to have different token offerings at increasing token prices. We intend to close each offering prior to the commencement of the next offering in accordance with each offering’s private placement memorandum.  For any and all investment decisions, purchasers must rely upon that certain private placement memorandum, as amended, not this website.

* Supply is fixed and cannot be increased in the future | ** See Timeline below for pricing details

ACCEPTED PAYMENTS

Fiat

(Fiat)

Bitcoin

(BTC)

All investors, both foreign and domestic, will be subject to U.S. anti-money laundering (AML) and know-your-customer (KYC) certification. In addition, all U.S. investors must undergo “accredited investor” qualification by a third party verification company.

TOKEN DISTRIBUTION

Total Supply 500M | Total Public Distribution 220M

39%
Public
5%
Community
36%
Reserve
20%
Founders & Employees

USE OF PROCEEDS

  • Product Development – We intend to use the proceeds of the STO principally to pay expenses associated with development of our tokenized ecosystem, the Vytalyx Blockchain, and our AI, the Vytalyx AI, for use in personalizing drugs, dietary supplements, clinical decision support (CDS), evidence-based medicine (EBM), nutrition and fitness
  • Operational, Administrative & General – We intend to use the proceeds of the STO principally to pay expenses associated with operations including but not limited to labor costs, operating costs and occupancy costs
  • Reserve – We intend to use the proceeds of the STO principally to pay expenses and allocations associated with various Company initiatives including but not limited to the development of a compounding facility.
  • Marketing & Business Development – We intend to use the proceeds of the STO principally to pay expenses associated with marketing, business development, creating brand awareness, sponsorships and brand ambassadors

TOKEN OFFERING TIMELINE (PROJECTED)*

EVENT INFORMATION
Duration of 1st Offering  3 Weeks subject to extension by Vytalyx
Duration of each subsequent Offering  2 Weeks subject to extension by Vytalyx
Offering No 1 (65M Tokens)  Token Price: $0.09 (**70% Discount)
Offering No 2 (65M Tokens) Token Price: $0.15 (**50% Discount
Offering No 3 (65M Tokens) Token Price: $0.225 (**25% Discount)
Projected Commencement of 1st Token Offering Date to be determined
9PM Singapore Time (UTC+8)
3PM Munich Time
9AM New York Time
2PM London Time
Projected End of 1st Token Offering Date to be determined
8:59PM Singapore Time (UTC+8)
2:59PM Munich Time
8:59AM New York Time
1:59PM London Time

* We reserve the right to issue additional tokens in the future. | ** Discount to anticipated full sales price of tokens in the future.

Vytalyx AI

Using analytics and data, lots of it, to figure out how you are wired.

Vytalyx

vitality |  the state of being strong and active; energy

WHO ARE WE?

We are a group of entrepreneurs and executives who have started, developed and scaled numerous companies. We have assembled a critical mass of seasoned professionals with a ballistic focus on creating innovation for the world.

Vytalyx

WE ARE A TEAM WITH OVER 750 YEARS

OF COLLECTIVE EXPERIENCE.

Collectively, the various Vytalyx teams bring over 7 centuries of aggregate experience to our enterprise with in-depth experience in executive leadership, augmented intelligence, blockchain, database engineering, software development, medicine, health science, genetics, chemistry, nutrition, engineering, pharmaceutical operations, dietary supplement manufacturing, quality assurance/quality control, marketing, legal, regulatory compliance, accounting, portfolio management, cryptoeconomics, capital markets and currency hedging.

0
NUMBER OF SKILLSETS
0
NUMBER OF TEAM MEMBERS
0
AVERAGE TEAM MEMBER AGE
0
COLLECTIVE YEARS OF EXPERIENCE

OUR MISSION

Vytalyx was founded with a commitment to developing products and services that could potentially change the world in which we live. Our model grew out of the abundant fragmentation in healthcare today and the desire to create a solution that exists at the intersection of nature vs nurture.  Our goal is to create technology, products and services that potentially solve many of the world’s complex health needs, both clinical and non-clinical, that are personalized and are conveniently accessible from anywhere in the world.  We believe innovations in new technologies and methodologies are often the catalyst to most scientific and commercial revolutions.  Innovation may foster exploration and ultimately, new concepts.  We believe that Vytalyx is at the apex of cutting-edge of technological innovation and we intend to create products and services that potentially help our customers look better, feel better and live better.

OUR EXPERIENCE

Various individuals on our management and advisory teams have broad and diverse backgrounds with the core experience required for each of our operational divisions. Below is a summary of the areas of experience our management and advisory teams have in aggregate.

Technology (AI, ML, DL, Blockchain, Database Engineering, Software Development, Data Warehousing)
26%
Corporate (Executive Leadership, Marketing, Finance)
13%
Sciences (Medicine, Genetics, Chemistry, Kinesiology, Nutrition)
12%
Pharmaceutical & Dietary Supplements Manufacturing (Design, Development, Engineering, Operations, Quality Control)
22%
Legal (503B, FDA, DEA, FTC, State, Corporate Law, ICO, SEC, CFTC)
4%
Compliance (FDA, DEA, SEC, CFTC, State/Federal, Corporate Practice of Medicine, Anti-Kickback, IQ, OQ, PQ)
23%
TOTAL
100%

MANAGEMENT TEAM

Our Management Team combines a unique blending of in-depth experience in executive leadership, medicine, genetics, pharmaceutical operations, dietary supplement and nutraceutical operations, biotechnology, AI, blockchain, software development, technology, chemistry, nutrition, engineering, marketing, legal, regulatory compliance, cryptoeconomics and accounting. Our team has a critical mass of seasoned professionals from diverse and complimentary backgrounds, which represent a unique blend of expertise from academia and in-depth industry expertise. This is a simple yet powerful model that requires an uncommon combination of skills and experience that very few organizations may offer.

David A. Granzotti
Co-Founder & Chief Executive Officer

Dr. Andre S. Granzotti MD
Co-Founder & Chief Medical Officer

John Hartwig
Chief Operating Officer

Jennifer Tanguy
Chief Marketing Officer

Jeffrey P. Heller
Chief Financial Officer

David P. Valenti
Chief Legal Officer

Gary Pike
Chief Blockchain Officer

Jonathan Tarr
Chief Chemist

BOARD OF DIRECTORS

We have built an experienced Board of Directors for strategic guidance on the various initiatives of Vytalyx. Our Board of Directors are committed to innovating in ways that empower our customers, our partners, and ultimately everyone in a healthier world.

David A. Granzotti
Chairman

Dr. Andre S. Granzotti MD
Director

Dave Wentz
Director

TECHNOLOGY ADVISORS

We have built an experienced team of third-party Technology Advisors for input and guidance on the various technology initiatives of Vytalyx, which include but are not limited to, EMR data warehousing, augmented intelligence, machine learning and blockchain.  Our technology Advisors may assist Vytalyx with the development of our AI, the Vytalyx AI, and our tokenized ecosystem and permissioned, the Vytalyx Blockchain, as well as assisting Vytalyx in determining various integrations, data inputs, data sources, API connections, network architectures, algorithms, use cases and AI theories for incorporation into the Vytalyx AI and the Vytalyx Blockchain.

Dale Sanders
EHR Data Warehousing

Dr. Asad Mahmood
AI & Blockchain

Eli Jawad Ansari
Blockchain

Yemo Adeyemo
Blockchain

Mattan Lurie
Blockchain

H.O. MayCotte
Database Technology

Ben Lamm
Artificial Intelligence

John Fremont
AI & Blockchain

Will Womble
Artificial Intelligence & Technology

Marc Boudria
Artificial Intelligence Engineer

Drew Lipman
AI, Blockchain & Data Science

Travis Turner
Technology & Software Engineering

Matt Jafee
Technology & Software Engineering

Alain Bernstein
Technology & Software Engineering

Todd Gruben
Technology & Software Engineering

Cody Soyland
Technology & Software Engineering

Jonathan Spillman
Technology & Operations

Angelo N. Granzotti
AI & Software Engineering

PHARMACEUTICAL ADVISORS

We have built an experienced team of third-party Pharmaceutical Advisors for input and guidance on: (i) the design, engineering, construction of our pharmaceutical compounding and dietary supplement manufacturing facilities; (ii) validating and qualifying our equipment, utilities and processes; (iii) pharmaceutical staff recruiting services; (iv) ongoing staff equipment and cGMP training; (v) ongoing pharmaceutical operations and preventative maintenance support; (vi) compounding operations; (vii) pharmacy operations and management.  Our Pharmaceutical Advisory team includes individuals with backgrounds in pharmaceutical and dietary supplement operations, compounding and pharmacy operations, cGMP, USP and FDA regulations and quality controls.

Robert Matje
Pharmaceutical Operations

Russell Teague
Pharmaceutical Operations

David Burgoss
Design, Validation & Qualification

Ray Wheeler
Pharmaceutical Project Engineering

Lois Horne
Quality Assurance & Regulatory Affairs

Bob Mehta
QA & Regulatory Compliance

George Harmon
Pharmaceutical Operations

Lance Lercher RPh
Pharmacy Management

Hayden Gharibyar
Compounding Pharmacy Operations

MEDICAL & SCIENCE ADVISORS

We have built an experience team of third-party Medical & Science Advisors for input and guidance on genetics, bioinformatics, metabolomics, proteomics, medical biology, medicine, personalized medicine, fitness and exercise science.

Dr. Rand McClain DO
Sports & Regenerative Medicine

Dr. Steve Sobol MD
Thyroid & ENT Medicine

Dr. Jordan Youngerman MD
Medicine

Heidi  Sexton APN, ACNP
Medicine

Dr. Mihnea Dumitrescu MD
Pain Management

Magda Orzechowska
Genetics & Medical Biotechnology

Dinesh Madhyastha
Genetics & Bioinformatics

Ryon Talbot
Fitness & Exercise Science

LEGAL ADVISORS

In conjunction with in-house general counsel, we have selected numerous law firms with industry specific legal experience to represent various facets of our business enterprise.

Edward Allera, Esq
Legal (FDA, DEA, Pharmaceuticals)

Rick Collins, Esq
Legal (FDA, DEA, Dietary Supplements)

Lee Rosebush, Esq
Legal (FDA, DEA, 503B Compounding)

Eric Madigan, Esq
Legal (Patents & Trademarks)

John Rivas, Esq
Legal (Stark, CPM, Anti-Kickback)

ONE SIZE DOESN’T FIT ALL

People want health solutions as unique as they are.

MEDIA

Austin Business Journal
Cision
Yahoo

CONTACT US

For whitelist inquiries, please enter your information below.